Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy (Hepatology International, (2021), 15, 5, (1031-1048), 10.1007/s12072-021-10239-x)

George Lau; Ming Lung Yu; Grace Wong; Alexander Thompson; Hasmik Ghazinian; Jin Lin Hou; Teerha Piratvisuth; Ji Dong Jia; Masashi Mizokami; Gregory Cheng; Guo Feng Chen; Zhen Wen Liu; Oidov Baatarkhuu; Ann Lii Cheng; Woon Leung Ng; Patrick Lau; Tony Mok; Jer Ming Chang; Saeed Hamid; A. Kadir Dokmeci; Rino A. Gani; Diana A. Payawal; Pierce Chow; Joong Won Park; Simone I. Strasser; Rosmawaiti Mohamed; Khin Maung Win; Tawesak Tanwandee; Shiv Kumar Sarin; Masao Omata

doi:10.1007/s12072-022-10301-2

Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy (Hepatology International, (2021), 15, 5, (1031-1048), 10.1007/s12072-021-10239-x)

George Lau, Ming Lung Yu, Grace Wong, Alexander Thompson, Hasmik Ghazinian, Jin Lin Hou, Teerha Piratvisuth, Ji Dong Jia, Masashi Mizokami, Gregory Cheng, Guo Feng Chen, Zhen Wen Liu, Oidov Baatarkhuu, Ann Lii Cheng, Woon Leung Ng, Patrick Lau, Tony Mok, Jer Ming Chang, Saeed Hamid, A. Kadir DokmeciRino A. Gani, Diana A. Payawal, Pierce Chow, Joong Won Park, Simone I. Strasser, Rosmawaiti Mohamed, Khin Maung Win, Tawesak Tanwandee, Shiv Kumar Sarin, Masao Omata

Department of Medicine, Medical College, Pakistan

Research output: Contribution to journal › Comment/debate

2 Citations (Scopus)

Abstract

Unfortunately, the first and last name of the Co-author, Tawesak Tanwandee has been interchanged in the original publication of the article. The correct first name should read as “Tawesak” and the last name should read as “Tanwandee” respectively.

Original language	English
Pages (from-to)	486-487
Number of pages	2
Journal	Hepatology International
Volume	16
Issue number	2
DOIs	https://doi.org/10.1007/s12072-022-10301-2
Publication status	Published - Apr 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s12072-022-10301-2

Fingerprint

Dive into the research topics of 'Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy (Hepatology International, (2021), 15, 5, (1031-1048), 10.1007/s12072-021-10239-x)'. Together they form a unique fingerprint.

Cite this

Lau, G., Yu, M. L., Wong, G., Thompson, A., Ghazinian, H., Hou, J. L., Piratvisuth, T., Jia, J. D., Mizokami, M., Cheng, G., Chen, G. F., Liu, Z. W., Baatarkhuu, O., Cheng, A. L., Ng, W. L., Lau, P., Mok, T., Chang, J. M., Hamid, S., ... Omata, M. (2022). Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy (Hepatology International, (2021), 15, 5, (1031-1048), 10.1007/s12072-021-10239-x). Hepatology International, 16(2), 486-487. https://doi.org/10.1007/s12072-022-10301-2

@article{dd693f47aa6f43fb9987858815ac56c9,

title = "Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy (Hepatology International, (2021), 15, 5, (1031-1048), 10.1007/s12072-021-10239-x)",

abstract = "Unfortunately, the first and last name of the Co-author, Tawesak Tanwandee has been interchanged in the original publication of the article. The correct first name should read as “Tawesak” and the last name should read as “Tanwandee” respectively.",

author = "George Lau and Yu, {Ming Lung} and Grace Wong and Alexander Thompson and Hasmik Ghazinian and Hou, {Jin Lin} and Teerha Piratvisuth and Jia, {Ji Dong} and Masashi Mizokami and Gregory Cheng and Chen, {Guo Feng} and Liu, {Zhen Wen} and Oidov Baatarkhuu and Cheng, {Ann Lii} and Ng, {Woon Leung} and Patrick Lau and Tony Mok and Chang, {Jer Ming} and Saeed Hamid and Dokmeci, {A. Kadir} and Gani, {Rino A.} and Payawal, {Diana A.} and Pierce Chow and Park, {Joong Won} and Strasser, {Simone I.} and Rosmawaiti Mohamed and Win, {Khin Maung} and Tawesak Tanwandee and Sarin, {Shiv Kumar} and Masao Omata",

note = "Publisher Copyright: {\textcopyright} Asian Pacific Association for the Study of the Liver 2022.",

year = "2022",

month = apr,

doi = "10.1007/s12072-022-10301-2",

language = "English",

volume = "16",

pages = "486--487",

journal = "Hepatology International",

issn = "1936-0533",

publisher = "Springer New York",

number = "2",

}

Lau, G, Yu, ML, Wong, G, Thompson, A, Ghazinian, H, Hou, JL, Piratvisuth, T, Jia, JD, Mizokami, M, Cheng, G, Chen, GF, Liu, ZW, Baatarkhuu, O, Cheng, AL, Ng, WL, Lau, P, Mok, T, Chang, JM, Hamid, S, Dokmeci, AK, Gani, RA, Payawal, DA, Chow, P, Park, JW, Strasser, SI, Mohamed, R, Win, KM, Tanwandee, T, Sarin, SK & Omata, M 2022, 'Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy (Hepatology International, (2021), 15, 5, (1031-1048), 10.1007/s12072-021-10239-x)', Hepatology International, vol. 16, no. 2, pp. 486-487. https://doi.org/10.1007/s12072-022-10301-2

Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy (Hepatology International, (2021), 15, 5, (1031-1048), 10.1007/s12072-021-10239-x). / Lau, George; Yu, Ming Lung; Wong, Grace et al.
In: Hepatology International, Vol. 16, No. 2, 04.2022, p. 486-487.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy (Hepatology International, (2021), 15, 5, (1031-1048), 10.1007/s12072-021-10239-x)

AU - Lau, George

AU - Yu, Ming Lung

AU - Wong, Grace

AU - Thompson, Alexander

AU - Ghazinian, Hasmik

AU - Hou, Jin Lin

AU - Piratvisuth, Teerha

AU - Jia, Ji Dong

AU - Mizokami, Masashi

AU - Cheng, Gregory

AU - Chen, Guo Feng

AU - Liu, Zhen Wen

AU - Baatarkhuu, Oidov

AU - Cheng, Ann Lii

AU - Ng, Woon Leung

AU - Lau, Patrick

AU - Mok, Tony

AU - Chang, Jer Ming

AU - Hamid, Saeed

AU - Dokmeci, A. Kadir

AU - Gani, Rino A.

AU - Payawal, Diana A.

AU - Chow, Pierce

AU - Park, Joong Won

AU - Strasser, Simone I.

AU - Mohamed, Rosmawaiti

AU - Win, Khin Maung

AU - Tanwandee, Tawesak

AU - Sarin, Shiv Kumar

AU - Omata, Masao

PY - 2022/4

Y1 - 2022/4

N2 - Unfortunately, the first and last name of the Co-author, Tawesak Tanwandee has been interchanged in the original publication of the article. The correct first name should read as “Tawesak” and the last name should read as “Tanwandee” respectively.

AB - Unfortunately, the first and last name of the Co-author, Tawesak Tanwandee has been interchanged in the original publication of the article. The correct first name should read as “Tawesak” and the last name should read as “Tanwandee” respectively.

UR - http://www.scopus.com/inward/record.url?scp=85123506604&partnerID=8YFLogxK

U2 - 10.1007/s12072-022-10301-2

DO - 10.1007/s12072-022-10301-2

M3 - Comment/debate

C2 - 35076895

AN - SCOPUS:85123506604

SN - 1936-0533

VL - 16

SP - 486

EP - 487

JO - Hepatology International

JF - Hepatology International

IS - 2

ER -

Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy (Hepatology International, (2021), 15, 5, (1031-1048), 10.1007/s12072-021-10239-x)

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this